Select for export P.324 Acute effects of psilocybin on glutamate concentration levels, functional connectivity and subjective state No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.12.087 Copy citation Copy BibTeX European Neuropsychopharmacology 2020-01-27 Natasha L. Mason, Kim P. C. Kuypers, Johannes T. Reckweg, Desmond H. Y. Tse, Felix Müller, Stefan W. Toennes OpenAlex Published psilocybin General Other More
Select for export Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2019.00955 PubMed 32038317 Copy citation Copy BibTeX Frontiers in Psychiatry 2020-01-21 Albert Garcia-Romeu, Alan K. Davis, Earth Erowid, Fire Erowid, Roland R. Griffiths, Matthew W. Johnson OpenAlex Published psilocybin AddictionChronic PainReceptor Pharmacology Observational Study More
Select for export Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881119895520 PubMed 31941394 Copy citation Copy BibTeX Journal of Psychopharmacology 2020-01-15 Lea J. Mertens, Matthew B. Wall, Leor Roseman, Lysia Demetriou, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionChronic PainBrain Imaging Other More
Select for export Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881119897615 PubMed 31916890 Copy citation Copy BibTeX Journal of Psychopharmacology 2020-01-08 Gabrielle Agin-Liebes, Tara C. Malone, Matthew M. Yalch, Sarah E. Mennenga, Katherine Ponte, Jeffrey Guss OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/hup.2719 PubMed 31909513 Copy citation Copy BibTeX Human Psychopharmacology Clinical and Experimental 2019-12-31 Joseph J. Palamar, Patricia Acosta OpenAlex Published psilocybin PharmacologyToxicity Qualitative Study More
Select for export Psychedelic Microdosing: A Subreddit Analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2019.1683260 PubMed 31648596 Copy citation Copy BibTeX Journal of psychoactive drugs 2019-12-31 Lea T, Amada N, Jungaberle H PubMed Published psilocybin DepressionAnxietyMicrodosing Other More
Select for export P.228 The polypharmacological profile of psilocybin and potential behavioural effects of very low doses No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.09.271 Copy citation Copy BibTeX European Neuropsychopharmacology 2019-11-30 K. Kiilerich, Nikolaj Speth, J. Lorenz, Agata Casado-Sainz, Vladimir Shalgunov, Denise Lange OpenAlex Published psilocybin PharmacologyOxidative Stress Other More
Select for export P.188 Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personality No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.09.232 Copy citation Copy BibTeX European Neuropsychopharmacology 2019-11-30 Mie Madsen, P.M. Fisher, D.S. Stenbæk, S. Kristiansen, D. Burmester, S. Lehel OpenAlex Published psilocybin Receptor PharmacologyPersonality Change Other More
Select for export P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.09.593 Copy citation Copy BibTeX European Neuropsychopharmacology 2019-11-30 Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris OpenAlex Published psilocybin DepressionMechanism of ActionEmotional Processing Clinical Trial More
Select for export P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levels No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2019.09.702 Copy citation Copy BibTeX European Neuropsychopharmacology 2019-11-30 Dea Siggaard Stenbæk, M.K. Madsen, Brice Ozenne, Søren Kristiansen, Daniel Burmester, David Erritzøe OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s12954-019-0333-3 PubMed 31779667 Copy citation Copy BibTeX Harm Reduction Journal 2019-11-27 Martin Andersson, Anette Kjellgren OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Qualitative Study More
Select for export Psychedelic microdosing benefits and challenges: an empirical codebook Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s12954-019-0308-4 PubMed 31288862 Copy citation Copy BibTeX Harm Reduction Journal 2019-07-08 Thomas Anderson, Rotem Petranker, Adam Christopher, Daniel Rosenbaum, Cory R. Weissman, Lê-Anh Dinh-Williams OpenAlex Published psilocybin AnxietyChronic PainPharmacology Qualitative Study More
Select for export Replication and extension of a model predicting response to psilocybin No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-019-05279-z PubMed 31203401 Copy citation Copy BibTeX Psychopharmacology 2019-06-14 Suzanne L. Russ, Robin Carhart-Harris, Geoffrey Maruyama, Melody S. Elliott OpenAlex Published psilocybin AnxietyPharmacologyToxicity Other More
Select for export Motives and Side-Effects of Microdosing With Psychedelics Among Users Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyz029 PubMed 31152167 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2019-05-29 Nadia R. P. W. Hutten, Natasha L. Mason, Patrick C. Dolder, Kim P. C. Kuypers OpenAlex Published psilocybin PharmacologyMicrodosingObservational Study Observational Study More
Select for export Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels No abstract availability was recorded for this entry. Details DOI 10.1038/s41386-019-0324-9 PubMed 30685771 Copy citation Copy BibTeX Neuropsychopharmacology 2019-01-25 M. Madsen, Patrick M. Fisher, Daniel Burmester, Agnete Dyssegaard, Dea Siggaard Stenbæk, Sara Kristiansen OpenAlex Published psilocybinpsilocin PharmacologyReceptor Pharmacology Other More
Select for export Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1037/pha0000253 PubMed 30628811 Copy citation Copy BibTeX Experimental and Clinical Psychopharmacology 2019-01-09 Farhana Sakloth, Elizabeth Leggett, Megan J. Moerke, E. Andrew Townsend, Matthew L. Banks, S. Stevens Negus OpenAlex Published psilocybin DepressionAddictionPharmacology Animal Study More
Select for export Psilocybin induces aberrant prediction error processing for tactile mismatch responses No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2018.11.477 Copy citation Copy BibTeX European Neuropsychopharmacology 2018-12-31 P. Dürler OpenAlex Published psilocybin DepressionAnxietyAddiction Other More
Select for export Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humans No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2018.11.474 Copy citation Copy BibTeX European Neuropsychopharmacology 2018-12-31 M. Madsen, Daniel Burmester, Dea Siggaard Stenbæk, Søren Kristiansen, Agnete Dyssegaard, Szabolcs Lehel OpenAlex Published psilocybinpsilocin Receptor Pharmacology Other More
Select for export Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881118793086 PubMed 30182795 Copy citation Copy BibTeX Journal of Psychopharmacology 2018-09-04 Leonard JB, Anderson B, Klein-Schwartz W. Europe PMC Published psilocybin AdolescentsSafetyToxicity Other More
Select for export Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-018-4981-x PubMed 30062577 Copy citation Copy BibTeX Psychopharmacology 2018-07-29 Barrett FS, Carbonaro TM, Hurwitz E, Johnson MW, Griffiths RR. Europe PMC Published psilocybin PharmacologyReceptor Pharmacology Other More
